CURR OPIN INVEST DR 润色咨询

Current Opinion in Investigational Drugs

出版年份:2000 年文章数:0 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=b8017377, cover=https://img.medsci.cn/images/journal/cover/2021/rYD_202109271314495230.jpg, fullname=Current Opinion in Investigational Drugs, abbr=CURR OPIN INVEST DR, pyear=2000, frequence=null, articleNumbers=0, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2018年中国人文章占该期刊总数量暂无数据 (2017年为暂无数据), issn=1472-4472, greenSci=https://www.greensci.net/search?kw=1472-4472, scijournal=https://www.scijournal.org/impact-factor-of-CURR-OPIN-INVEST-DR.shtml, medsciHotlightString=null, medsciHotlightRealtime=0.687, medsciHotlight=0.634, medsciHotlight5year=1.13551, citescore=0.0, hIndex=71, impactFactor=null, orgnization=Current Drugs Ltd., orgnizationUrl=http://thomsoncurrentdrugs.com, country=United Kingdom, countryCn=英国, isOa=0, isOaString=否, sciScie=null, bigclassCas=null, smallclassCas=, website=http://pubget.com/journal/1472-4472/current-opinion-in-investigational-drugs, websiteHits=3174, guideForAuthor=null, guideForAuthorHits=1, submitWebsite=, submitWebsiteHits=1, content=Published by Thomson Current Drugs. ISSN: 1472-4472.<br /><br />Current Opinion in Investigational Drugs is a monthly publication covering all therapeutic areas, in recognition of the increasingly multi-disciplinary nature of modern drug discovery and development. With Current Opinion in Investigational Drugs, we aim to help the reader by providing in a systematic manne critical reviews of selected areas of investigational drug research, expert evaluation of selected drugs currently in clinical trials, selection of the most interesting papers and patents, annotated by experts. Six therapeutic categories are covered with each being featured in separate journal issues, and each therapeutic area being covered twice-yearly. The broad therapeutic categories and the specialist topics within each are as follows: Anti-infectives Antifungals and antiparasitics; antibacterials (b-lactams, glycopeptides and other agents); antibacterials (quinolones, macrolides and oxazolidinones); vaccines; antivirals (HIV); antivirals (non-HIV); Anti-inflammatory, Immunologicals and Biologicals Musculoskeletal; respiratory; dermatology; nervous system; transplantation; Cardiovascular and Renal Hypertension and renal failure; stroke and angina; arrhythmia and heart failure; antithrombotics; hemostasis and hematological diseases; atherosclerosis, hypercholesterolemia and heart disease; Endocrine and and Metabolics Diabetes, reproductive endocrinology, hormone disorders, bone metabolism and obesity; Central and Peripheral Nervous System Pain; neuro-urology and neurogastroenterology; neurodegenerative and cognitive disorders; affective/behavioral/personality disorders and substance abuse; neurology and neuroprotection; schizophrenia and psychosis; Oncological Cell signaling modulators; cytotoxic drugs; immunotherapeutic drugs and monoclonal antibodies; protein therapeutics, including growth factors; gene therapy; antisense inhibitors, totalCites=null, brief=CURR OPIN INVEST DR杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的中等级别杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=b8017377'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2012, citescore=0.0), GetImpactFactorCiteScoreListResponse(year=2013, citescore=0.0), GetImpactFactorCiteScoreListResponse(year=2014, citescore=0.0), GetImpactFactorCiteScoreListResponse(year=2017, citescore=0.13), GetImpactFactorCiteScoreListResponse(year=2018, citescore=37.26)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2019, medsciHotlight=2.197), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=0.56), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=0.688), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=0.91), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=0.687)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1472-4472[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Current Opinion in Investigational Drugs[ta], article_number=0, article_number_cn=null, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
CURR OPIN INVEST DR/Current Opinion in Investigational Drugs
ISSN
1472-4472
影响指数话题
预警等级
MedSci期刊指数
0.687 (MedSci实时期刊指数) | 1.13551 (5年期刊指数)
CiteScore值
0.0
h-index
71
h5-median
暂无数据
出版社/管理机构
杂志由 Current Drugs Ltd. 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
暂无数据
出版年份
2000
是否OA
被收录情况
暂无数据
JCR分区
暂无数据
中科院分区
大类:
小类: